EXAS Stock Rises 19%: Key Insights from Our Data Analysis
EXAS stock has seen a significant uptick of 19% recently. This increase was recorded amidst a trading volume of approximately $645 million. The stock was also the 571st most-searched ticker among over 10,000 tickers on Quiver Quantitative in the last 24 hours.
Insider Trading Activity for EXAS
In the past six months, insiders have conducted seven trades involving EXAS stock, all of which were sales. Notably, no purchases were recorded during this period.
- Katherine S. Zanotti sold 15,207 shares for approximately $950,612.
- Brian Baranick sold 2,858 shares for around $200,288.
- James Herriott sold 3,000 shares for about $195,120.
- James Edward Doyle sold 3,485 shares for an estimated $182,399.
The lack of purchases by insiders may raise questions among potential investors.
Institutional Hedge Fund Activity
During the last quarter, a notable shift was observed among institutional investors. Specifically, 275 investors increased their EXAS holdings, while 321 reduced their investments.
- FMR LLC reduced its position by 30.6%, shedding 8,241,935 shares.
- Wellington Management Group lowered its holdings by 55.6%, selling 6,677,809 shares.
- Conversely, Citadel Advisors amplified its investment by 805.1%, acquiring 3,506,084 shares.
- Canada Pension Plan Investment Board added 2,500,056 shares, marking a 2439.1% increase.
- Ameriprise Financial raised its stake by 102.1% with an additional 2,270,039 shares.
- ARK Investment Management remarkably increased its position by over 6072588.9%, purchasing 2,186,132 shares.
Government Contracts
In the last year, EXAS has secured $592,152 in government contract payments. These awards reflect the company’s ongoing collaboration with public entities.
Analyst Ratings and Price Targets
Wall Street analysts are generally optimistic about EXAS. Over the past several months, seven firms have issued buy ratings, with no sell ratings reported.
Here are some notable analyst ratings:
- Piper Sandler offered an “Overweight” rating on November 11, 2025.
- TD Cowen and BTIG both rated it as a “Buy” on November 4, 2025.
- Baird provided an “Outperform” rating on the same day.
- Evercore ISI Group rated it as “Outperform” on October 7, 2025.
Recently, thirteen analysts set price targets for EXAS. The median target stands at $80. Here are some of the most recent predictions:
- David Westenberg from Piper Sandler: $80.0
- Brandon Couillard from Wells Fargo: $85.0
- Catherine Schulte from Baird: $88.0
- Subbu Nambi from Guggenheim: $75.0
- Luke Sergott from Barclays: $77.0
Investors should monitor these developments closely as they could influence future performance.
This article is brought to you by El-Balad. For more information on EXAS stock, please refer to our detailed analysis and insights.
